BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14579898)

  • 1. Natural history and clinical management of optic pathway glioma.
    Astrup J
    Br J Neurosurg; 2003 Aug; 17(4):327-35. PubMed ID: 14579898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
    Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
    Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1.
    Sellmer L; Farschtschi S; Marangoni M; Heran MKS; Birch P; Wenzel R; Mautner VF; Friedman JM
    Orphanet J Rare Dis; 2018 Apr; 13(1):62. PubMed ID: 29685181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
    Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R
    J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optic glioma warranting treatment in children.
    Kaufman LM; Doroftei O
    Eye (Lond); 2006 Oct; 20(10):1149-64. PubMed ID: 17019413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.
    Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK
    J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
    Trevisson E; Cassina M; Opocher E; Vicenzi V; Lucchetta M; Parrozzani R; Miglionico G; Mardari R; Viscardi E; Midena E; Clementi M
    J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manifestations and Treatment of Adult-onset Symptomatic Optic Pathway Glioma in Neurofibromatosis Type 1.
    Mehlan J; Schüttauf F; Salamon JM; Kordes U; Friedrich RE; Mautner VF
    Anticancer Res; 2019 Feb; 39(2):827-831. PubMed ID: 30711963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre.
    Grill J; Laithier V; Rodriguez D; Raquin MA; Pierre-Kahn A; Kalifa C
    Eur J Pediatr; 2000 Sep; 159(9):692-6. PubMed ID: 11014471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital.
    Rony C; Aharoni S; Halevy A
    Neuropediatrics; 2022 Oct; 53(5):370-375. PubMed ID: 35381604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
    Freret ME; Gutmann DH
    J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prechiasmatic transection of the optic nerve in optic nerve glioma: technical description and surgical outcome.
    Borghei-Razavi H; Shibao S; Schick U
    Neurosurg Rev; 2017 Jan; 40(1):135-141. PubMed ID: 27230830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.
    Listernick R; Ferner RE; Liu GT; Gutmann DH
    Ann Neurol; 2007 Mar; 61(3):189-98. PubMed ID: 17387725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1 and sporadic optic gliomas.
    Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
    Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous regression of low-grade astrocytomas in childhood.
    Schmandt SM; Packer RJ; Vezina LG; Jane J
    Pediatr Neurosurg; 2000 Mar; 32(3):132-6. PubMed ID: 10867559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
    Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
    Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management options for visual pathway compression from optic gliomas.
    Bessero AC; Fraser C; Acheson J; Davagnanam I
    Postgrad Med J; 2013 Jan; 89(1047):47-51. PubMed ID: 23001214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.